• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Healthcare

Strapping Names From the Start-Up Nation

For high-growth Israeli names, this list is a great starting point.
By GARY DVORCHAK
Feb 06, 2013 | 10:30 AM EST
Stocks quotes in this article: ESLT, GIVN, PERI, PTNR

"Some Americans have come to the Middle East looking for oil. We came to the Middle East looking for brains, and we stopped at Israel." -- Warren Buffet, September 2006

I am a huge fan of Israel as a source of great growth-stock ideas -- at a reasonable price, no less. I have been investing in Israeli tech stocks since the mid-1990s, and with great success. The country never fails to produce a steady flow of new ideas, technical talent and high-growth companies. For a variety of reasons, high-growth Israeli companies usually garner a lower multiple than do their Silicon Valley brethren, making the region a dream for managers focusing on companies with growth at a reasonable price (GARP). How has the "Start-Up Nation" been doing lately?

In order to answer that question, I attended a recent dinner here in Los Angeles sponsored by OurCrowd, a new crowd-sourcing venture-capital site that's funding the next generation of hot Israeli startups. OurCrowd was founded by Jonathan Medved -- a prominent Israeli VC who coined the term "Start Up Nation," and is featured in the book of the same name. Speaking in LA was OurCrowd partner Elan Zivotofsky, a veteran investor in Israeli tech companies. Elan has covered Israeli tech as both a sell-side analyst for Goldman Sachs, and on the buy side at several highly regarded funds. He is considered an axe on the space.

Elan started by pointing out that the country has an incredibly solid infrastructure for producing bright minds that can build high-tech companies. A variety of sources confirm that Israel has institutions and the high spending in research and development that lead to innovation. Consider where Israel ranks: No. 1 in the world in medical-device patents per capita; No. 3 in the world for total patents per capita; third most scientific papers per capita in the world; and No. 2 in the world in public expenditure on education.

Israeli R&D

Also important to note is that Israel is home to R&D offices for all of the major tech companies, producing a steady stream of highly experienced experts that can then provide the talent needed for successful startups.

Israeli R&D

In addition, the country attracts a high level of venture capital -- most recently, it saw $2 billion in new funding rounds.

Capital Raised by Israeli High-Tech Companies
Source: IVC Research Center
View Chart » View in New Window »

In an environment like this, it pays to examine the opportunities already out and growing in the public markets. I ran a screen of Israeli companies traded in the U.S. market with market capitalization of $10 million or higher (the region does skew toward small-cap). The table below is a great starting point for your research into high-growth Israeli names.

Israeli Companies on U.S. Exchanges
Source: FactSet
View Chart » View in New Window »

A couple of items stand out. Naturally, the list is heavy with technology names, which should not be surprising. Beyond the attractive infrastructure about which Elan elaborated, consider geography. With a tiny domestic market, "domestic-only" types of companies will rapidly run out of room to grow. Home-grown companies must export to get large, and technology products have an instant global market with little in the way of cultural barriers. Having said that, there are a handful of consumer-type names that have managed to create global brands and can be found in the table.

Several names caught my attention for the combination of high near-term growth and low valuation. These are highlighted and include: defense systems vendor Elbit Systems (ESLT), medical-device pioneer Given Imaging (GIVN), Internet-media leader Perion Network (PERI), and telecom name Partner Communications (PTNR). These are joined by a roster of high-growth names with reasonable -- although not low -- valuations. Any investor interested in exposure to Israel should be able to get comfortable with more than a handful of the names in this table.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Dvorchak had no positions in the stocks mentioned.

TAGS: Investing | Global Equity | Healthcare | Technology

More from Healthcare

Boston Scientific Could Be Wicked Good in This Kind of Market

Brad Ginesin
May 24, 2022 2:13 PM EDT

Here's why this healthcare stock is a potential port in the storm for investors.

2 Biotech Stocks to Own as M&A Potentially Gathers Steam

Bret Jensen
May 11, 2022 11:35 AM EDT

I like these names as stand-alone entities but they should also attract interest from larger players.

China Faces 'Tsunami' of Covid Infection That Could Swamp the System

Alex Frew McMillan
May 11, 2022 9:00 AM EDT

A new study suggests 1.55 million people could die if China abandons zero-Covid, with the intensive-care system needing 15.6 times existing capacity.

I'm Giving Dynavax Another Shot -- a Booster Shot

Bret Jensen
May 8, 2022 7:31 AM EDT

Despite an earnings miss, DVAX show promise in several vaccine fronts and I'm doubling down on the name.

In This Environment, I'd Be More Risk Averse With Intuitive Surgical

Stephen Guilfoyle
Apr 25, 2022 10:50 AM EDT

The firm has been hurt and continues to be hurt by the effects of the pandemic.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 02:46 PM EDT STEPHEN GUILFOYLE

    We're Shedding Some of This Holding on Strength

    Check out the Stocks Under $10 portfolio here!
  • 11:33 AM EDT PETER TCHIR

    Thoughts Ahead of the Fed Minutes

    Recent economic and earnings issues are convincing...
  • 02:24 PM EDT PAUL PRICE

    An Interesting Chart

    I'm betting heavily that stocks will be way up aga...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login